Patent ID: 11911456
Assignee: VACTECH OY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 7:
8. A method of inducing an immune response to coxsackie B virus (CBV) in a subject who is at increased risk of developing type 1 diabetes (T1D), the method comprising administering to the subject an effective amount of a composition comprising:
a) a nucleic acid encoding a protein or peptide comprising a viral antigenic epitope of CBV1 and a nucleic acid encoding a protein or peptide comprising a viral antigenic epitope of CBV2; and
b) at least one nucleic acid selected from a nucleic acid encoding a protein or peptide comprising a viral antigenic epitope of CBV3, a nucleic acid encoding a protein or peptide comprising a viral antigenic epitope of CBV4, and a nucleic acid encoding a protein or peptide comprising a viral antigenic epitope of CBV5, wherein the composition does not include a nucleic acid encoding a protein or peptide comprising a viral antigenic epitope of CBV6,
wherein said administering induces an immune response to CBV in the subject.